We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$17B
AUM Growth
-$2.09B
Cap. Flow
-$1.4B
Cap. Flow %
-8.24%
Top 10 Hldgs %
32.24%
Holding
303
New
25
Increased
89
Reduced
109
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 45.69%
2 Healthcare 18.55%
3 Financials 15.91%
4 Communication Services 12.03%
5 Consumer Discretionary 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
101
First American
FAF
$7.33B
$36.4M 0.21%
675,000
BRO icon
102
Brown & Brown
BRO
$22.1B
$35.8M 0.21%
400,000
+50,000
+14% +$4.34M
MMSI icon
103
Merit Medical Systems
MMSI
$5.2B
$35.5M 0.21%
412,765
MDGL icon
104
Madrigal Pharmaceuticals
MDGL
$12.3B
$35.1M 0.21%
125,300
+95
+0.1% +$22.6K
DXCM icon
105
DexCom
DXCM
$31.3B
$34.6M 0.2%
305,186
+62,186
+26% +$7.86M
FIS icon
106
Fidelity National Information Services
FIS
$19.7B
$34M 0.2%
451,512
+109,098
+32% +$8.08M
IBKR icon
107
Interactive Brokers
IBKR
$41.1B
$31M 0.18%
1,012,812
-405,108
-29% -$12.1M
CRH icon
108
CRH
CRH
$59.2B
$30.7M 0.18%
409,473
-86,127
-17% -$6.87M
CGON icon
109
CG Oncology
CGON
$6.41B
$30.5M 0.18%
967,055
+237,889
+33% +$8.25M
NTNX icon
110
Nutanix
NTNX
$18.3B
$30.3M 0.18%
533,300
-159,377
-23% -$9.78M
MLTX icon
111
MoonLake Immunotherapeutics
MLTX
$1.08B
$29.8M 0.18%
678,169
-179,788
-21% -$7.62M
SPGI icon
112
S&P Global
SPGI
$123B
$29.4M 0.17%
65,833
+7,216
+12% +$3.1M
BDX icon
113
Becton Dickinson
BDX
$48.4B
$29M 0.17%
124,013
-6,164
-5% -$1.45M
ADI icon
114
Analog Devices
ADI
$175B
$28.7M 0.17%
125,800
-16,242
-11% -$3.47M
LIN icon
115
Linde
LIN
$214B
$27.7M 0.16%
63,155
-4,250
-6% -$1.87M
PODD icon
116
Insulet
PODD
$9.56B
$26.4M 0.16%
130,881
-31,062
-19% -$5.6M
MIRM icon
117
Mirum Pharmaceuticals
MIRM
$6.28B
$25.3M 0.15%
741,049
+116,049
+19% +$3.04M
ESTA icon
118
Establishment Labs
ESTA
$2.14B
$24.8M 0.15%
546,519
SRRK icon
119
Scholar Rock
SRRK
$6.31B
$24.5M 0.14%
2,940,672
VERA icon
120
Vera Therapeutics
VERA
$2.45B
$24.4M 0.14%
675,000
USFD icon
121
US Foods
USFD
$20.5B
$24.4M 0.14%
460,124
-4,403
-0.9% -$232K
WMT icon
122
Walmart Inc
WMT
$865B
$24.4M 0.14%
359,752
+58,027
+19% +$3.65M
YMAB
123
DELISTED
Y-mAbs Therapeutics
YMAB
$22.1M 0.13%
1,831,000
NUVL
124
DELISTED
Nuvalent
NUVL
$21.8M 0.13%
+287,500
New +$20.5M
PLRX icon
125
Pliant Therapeutics
PLRX
$72.4M
$21.7M 0.13%
2,015,000

Similar funds

Polar Capital Holdings's Q2 2024 Portfolio in Review

As of Q2 2024, Polar Capital Holdings held 303 positions worth $17B, down 11% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Polar Capital Holdings withdrew a net $1.4B in Q2 2024, closing 31 positions and reducing 109 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in First Solar worth $105M.

  • Polar Capital Holdings's largest Q2 2024 buy was First Solar: 463,764 shares worth $105M.
  • Polar Capital Holdings added most to Broadcom in Q2 2024, an estimated $187M increase.
  • Polar Capital Holdings's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $273M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q2 2024, selling an estimated $783M.
  • Polar Capital Holdings's ten largest holdings make up 32% of its $17B portfolio in Q2 2024.
  • Polar Capital Holdings opened 25 new positions and closed 31 in Q2 2024.
  • Polar Capital Holdings's portfolio value fell 11% quarter-over-quarter to $17B.

Based on Polar Capital Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.